Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Vir initiates phase I trial of HIV T-cell vaccine VIR-1111

Jan. 8, 2021

European Commission approves cabotegravir and rilpivirine long-acting injectable for HIV

Dec. 22, 2020

Merck & Co. discovers new compounds for HIV infection

Dec. 16, 2020

ViiV Healthcare divulges new HIV1 inhibitors

Nov. 24, 2020

Phase II/III CAPELLA study of lenacapavir meets primary endpoint

Nov. 19, 2020

Gilead Sciences patents HIV protease inhibitors

Nov. 10, 2020

Merck & Co. synthesizes new compounds for HIV infection

Oct. 29, 2020

Orion's OB-002H for prevention of HIV completes first-in-human study

Oct. 19, 2020

Test tube HIV enables replication insights

Oct. 14, 2020

T-cell 'repliclones' can thwart HIV drugs

Oct. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...